From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA expands approval of Bristol-Myers Squibb myeloid leukemia treatment

from Pharmaceutical Processing

U.S. Food and Drug Administration expands approval of Sprycel (dasatinib) to include treatment of children with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063